Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting.

ABSTRACT:

Background

Evidence-based International clinical practice guidelines, universally recommend secondary prevention medications for those with previous cardiovascular disease (CVD). There is limited data on the community use of these medications in the Middle East (ME).

Objectives

This study assesses the use and predictors of evidence based secondary prevention medications in individuals with a history of CVD [coronary heart disease (CHD) or stroke].

Methods

Between 2005 and 2015, we enrolled 11,228 individuals aged between 35-70 years from 52 urban and 35 rural communities from four ME countries, United Arab Emirates (n = 1499), Kingdom of Saudi Arabia (n = 2046), Occupied Palestinian Territory (n = 1668) and Islamic Republic of Iran (n = 6013). With standardized questi

SUBMITTER: Yusufali A 

PROVIDER: S-EPMC11363892 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature